Low-Dose Aspirin
Daily low-dose aspirin (75-100mg) for cardiovascular protection and cancer prevention, with important age and weight considerations.
Bottom Line
Low-dose aspirin is one of the most studied OTC interventions with proven cardiovascular benefits and emerging cancer prevention data. However, recent guideline changes have made it more nuanced, it's no longer recommended for everyone.
The evidence is strong for:
- Reducing heart attacks and strokes in high-risk individuals (40-59)
- Colorectal cancer prevention (55% reduction in recurrence in 2025 data)
- Anti-inflammatory effects via NF-κB and COX-2 suppression
The caveats are significant:
- Not recommended to START in adults 60+ (bleeding risk outweighs benefit)
- Low-dose (75-100mg) works best for people under 70kg
- Bleeding risk (GI and intracranial) increases with age
- ASPREE trial showed possible increased advanced cancer risk in 70+
If you're 40-59 with elevated cardiovascular risk and weigh under 70kg, low-dose aspirin may offer meaningful protection. For others, the risk/benefit calculation is less favorable. Always discuss with your doctor, this is not a supplement to take casually.
Science
Mechanisms of Action
Aspirin (acetylsalicylic acid) works through multiple pathways:
COX Inhibition:
- Irreversibly inhibits cyclooxygenase-1 (COX-1) and COX-2
- Reduces thromboxane A2 production → anti-platelet effect
- Reduces prostaglandin synthesis → anti-inflammatory
NF-κB Suppression:
- Inhibits nuclear factor kappa-B activation
- Suppresses downstream inflammatory genes (COX-2, iNOS, VCAM-1, ICAM-1)
- Blocks phosphorylation of IκBα
Antioxidant Effects:
- Reduces reactive oxygen species
- Inhibits nuclear translocation of thioredoxin
- May reduce oxidative damage associated with aging
Cancer Prevention Mechanisms:
- COX-2 inhibition reduces tumor-promoting prostaglandins
- Anti-platelet effect may reduce metastatic spread
- Direct effects on cell proliferation pathways
- Strongest evidence for colorectal cancer
The Weight Factor
A landmark 2018 Lancet analysis revealed that body weight significantly affects aspirin efficacy:
| Weight | Low-Dose (75-100mg) Benefit |
|---|---|
| 50-69 kg | Substantial CVD reduction |
| 70+ kg | No significant benefit |
| 70+ kg | Increased case fatality |
Higher doses (300-325mg) may be needed for heavier individuals, but this increases bleeding risk.
Age Considerations
The risk/benefit ratio shifts dramatically with age:
- Under 40: Generally not recommended (low baseline risk)
- 40-59: Consider if 10-year CVD risk ≥10%
- 60-69: Weaker recommendation, individual decision
- 70+: Generally NOT recommended to initiate (USPSTF 2022)
The ASPREE trial (19,114 adults 70+) found daily low-dose aspirin did not prolong healthy survival and was associated with increased bleeding and possibly higher cancer mortality.
Supporting Studies
7 peer-reviewed studies
View all studies & compare research →Practical Protocol
Standard Protocol
Dose:
- 75-100mg daily (81mg "baby aspirin" in US)
- Take with food to reduce GI irritation
- Enteric-coated may reduce stomach upset (though absorption is slower)
Timing:
- Morning or evening, consistency matters more than timing
- Some evidence for evening dosing improving blood pressure effects
Who Should Consider:
- Adults 40-59 with elevated 10-year CVD risk (≥10%)
- Those with history of cardiovascular events (secondary prevention)
- Body weight under 70kg for low-dose efficacy
- Those with Lynch syndrome or high colorectal cancer risk
Who Should NOT Take:
- Adults 60+ without existing CVD (don't initiate)
- History of GI bleeding or ulcers
- Bleeding disorders
- Allergy to NSAIDs
- Taking anticoagulants (warfarin, etc.)
- Uncontrolled hypertension
Weight-Based Considerations
| Your Weight | Recommended Approach |
|---|---|
| Under 70kg | Standard 75-100mg may work |
| 70-90kg | Discuss higher dose with doctor |
| Over 90kg | Low-dose likely insufficient |
Duration
- Benefits accrue over years of use
- Stopping suddenly after long-term use may cause rebound cardiovascular events
- If stopping, discuss tapering with physician
Risks & Side Effects
Bleeding Risks
Gastrointestinal:
- Increased risk of stomach/intestinal bleeding
- Risk increases with age, alcohol use, H. pylori infection
- Symptoms: black/tarry stools, stomach pain, vomiting blood
Intracranial:
- Small increased risk of hemorrhagic stroke
- More concerning in those with uncontrolled hypertension
Risk Factors for Bleeding:
- Age 70+
- History of GI bleeding
- Concurrent NSAID use
- Anticoagulant use
- Heavy alcohol consumption
- H. pylori infection
- Uncontrolled hypertension
Other Side Effects
- Tinnitus (ringing in ears) - usually at higher doses
- Allergic reactions (rare but can be severe)
- Reye's syndrome in children with viral illness (do not give to children)
Drug Interactions
- Anticoagulants: Increased bleeding risk
- Other NSAIDs: May reduce aspirin's cardioprotective effect
- SSRIs: Increased GI bleeding risk
- Methotrexate: Increased toxicity
- ACE inhibitors: May reduce effectiveness
The ASPREE Warning
The ASPREE trial in adults 70+ found:
- No reduction in cardiovascular events
- Increased major bleeding
- Possible increase in cancer-related deaths
- No extension of disability-free survival
This led to updated guidelines recommending against initiating aspirin in this age group.
Who It's For
Ideal Candidates
- High CVD risk adults 40-59 with 10-year risk ≥10%
- Secondary prevention (history of heart attack/stroke)
- Lynch syndrome or high familial colorectal cancer risk
- Body weight under 70kg (for low-dose efficacy)
- No history of bleeding problems
May Benefit
- Adults 50-59 with moderate CVD risk factors
- Family history of colorectal cancer
- Those already tolerating aspirin well for years
Probably Should Avoid
- Adults 60+ without established CVD (don't start)
- Body weight over 80kg (low-dose may be ineffective)
- History of GI bleeding or ulcers
- Taking blood thinners
- Uncontrolled high blood pressure
Definitely Avoid
- Aspirin or NSAID allergy
- Active bleeding disorder
- Severe liver or kidney disease
- Children and teenagers (Reye's syndrome risk)
- Pregnancy (especially third trimester)
How to Track Results
What to Monitor
Watch for Warning Signs:
- Black or tarry stools (GI bleeding)
- Unusual bruising
- Prolonged bleeding from cuts
- Blood in urine
- Severe headache (could indicate intracranial bleeding)
Regular Check-ups:
- Annual discussion with doctor about continuing
- Blood pressure monitoring
- Periodic CBC if on long-term therapy
Risk Assessment Tools:
- ASCVD Risk Calculator (for cardiovascular risk)
- HAS-BLED score (bleeding risk)
Signs to Stop and Seek Care:
- Vomiting blood or coffee-ground material
- Severe stomach pain
- Signs of allergic reaction
- Unexplained severe headache
Top Products
Standard Options:
- Bayer Low-Dose Aspirin 81mg - Brand name, enteric-coated
- Kirkland Low-Dose Aspirin - Costco generic, good value
- CVS/Walgreens Generic 81mg - Store brands work identically
Notes:
- Generic aspirin is chemically identical to brand name
- Enteric coating may reduce stomach irritation
- No meaningful quality difference between brands
- This is one intervention where cheap generic is perfectly fine
Cost Breakdown
Monthly Cost: $1-3/month
| Option | Price | Per Day |
|---|---|---|
| Generic 81mg (500ct) | $10-15 | ~$0.02 |
| Bayer brand (300ct) | $15-20 | ~$0.06 |
| Enteric-coated generic | $12-18 | ~$0.04 |
Cost-Benefit:
This is one of the cheapest interventions available. The limiting factor is not cost but whether you're an appropriate candidate based on age, weight, and risk factors.
Recommended Reading
- Aspirin: The Remarkable Story of a Wonder Drug View →
Podcasts
Using Existing Drugs in New Ways to Treat & Cure Diseases of Brain & Body | Dr. David Fajgenbaum
Most drugs bind to 20-30 proteins but are only approved for one use, leaving massive therapeutic...
Essentials: Science of Mindsets for Health & Performance | Dr. Alia Crum
Believing a milkshake is indulgent causes 3x greater ghrelin suppression than thinking it's...
#061 Q&A with Dr. Jed Fahey on Sulforaphane, Moringa and Chemoprotection
Optimal sulforaphane intake is 5-60mg daily for health benefits, with broccoli sprouts...
250. When You Should Worry About LDL Cholesterol with Mike Fave
Paul Saladino and Mike Fave unpack their views on lipids, true cardiovascular disease risk, and...
Discussed in Podcasts
35 curated moments from top health podcasts. Click any timestamp to play.
How Aspirin Affects Placental Blood Vessel Formation
Dr. Coy explains the biologic rationale for aspirin in preeclampsia prevention, including how it affects thromboxane and prostacyclin balance in placental vasculature.
"aspirin affects some of the hormones that guide and interact with these blood vessels in the placenta. Some hormones, things that are called from boxing, for example, and these are not hormones that everybody's familiar with, but it affects the balance of them"
15% Preeclampsia Reduction Plus Multiple Secondary Benefits
Dr. Coy presents the magnitude of aspirin's benefits, including roughly 15% reduction in preeclampsia and about 20% reduction in preterm birth, fetal growth restriction, and perinatal mortality.
"there was about a 15% reduction in the risk of developing preeclampsia by just taking a low-dose aspirin daily. But importantly, in addition to the risk of preeclampsia being reduced, there was a reduction in the risk of preterm birth, a reduction in the risk of fetal growth restriction"
Risk Stratification for Aspirin in Pregnancy
Dr. Coy walks through the USPSTF risk categories, explaining that one high-risk factor or two moderate risk factors qualifies a patient for low-dose aspirin.
"a Black woman who was also above the age of 35, that'd be two moderate risk factors, and that person should be recommended to take low-dose aspirin for the prevention of preeclampsia"
The Evolving Dosing Debate - 81 mg vs 150-162 mg
Dr. Chapa introduces the central question of whether 81 mg aspirin is sufficient for preeclampsia prevention or if higher doses of 150-162 mg are needed based on evolving evidence.
"Is 81 milligrams a day the current dose recommended in the U.S.?"
ACOG Risk Stratification for Aspirin in Pregnancy
Review of how ACOG has expanded its risk algorithm since 2013, adding Black race, lower socioeconomic status, and IVF as moderate risk factors in the 2018 and 2021 updates.
"We've got several things that we're going to talk about in this episode, including the last ACOG practice advisory, which was December 2021, that came off the heels of the U.S. Preventative Service Task Force expansion of criteria, basically expanding the moderate risk to include black race and lower socioeconomic status. All right. So those have been the recent releases from the college."
Meta-Analysis Evidence for Dose-Response Effect
Stephanie Roberge's 2017 meta-analysis of 45 randomized trials and nearly 20,000 participants demonstrated a dose-response relationship, with the greatest preeclampsia risk reduction seen above 100 mg.
"If you're ever asked, so what is more important, the dose of aspirin or when you start it? The answer is yes. Okay. Yes. Both the dose and the timing of initiation impact the effectiveness regarding preeclampsia prevention. They both have a role here. One of the biggest meta-analysis of RCTs that looked at this was in 2017."
Yellow vs orange vs red blue-light-blocking lenses explained
Dr. Cabral explains the differences between yellow, orange, and red blue-light lenses, clarifying when to wear each type and how much blue light they actually filter for sleep and eye health optimization.
"Differences between yellow, orange, and red blue-light-blocking lenses"
Aspirin and colon cancer risk in large-scale study
Cabral reviews a major study of over 124,000 participants examining the relationship between aspirin use and colon cancer risk, discussing the evidence for and against regular low-dose aspirin for prevention.
"A study on aspirin and colon cancer risk involving over 124,000 participants"
Most effective treatments for osteoarthritis joint pain
The episode covers research on the most effective treatments for osteoarthritis-related joint pain, emphasizing how the body adapts before it breaks and the importance of progressive loading.
"Your body adapts before it breaks"
The Dose Controversy - 81 mg vs 162 mg Aspirin
Dr. Chapa lays out the central controversy around aspirin dosing for preeclampsia prevention, noting that while ACOG still endorses 81 mg, evidence increasingly favors 162 mg.
"Should it be universal? Should we still stick with a risk-based approach? And the biggest controversy of all, of course, is the dose. Is it 81 milligrams? Should it be 150? Should it be double two baby aspirins in the U.S.? In other words, taking two 81 milligrams or 162?"
162 mg Reduces Preeclampsia Without Increased Bleeding
The Henry Ford study found significantly lower preeclampsia rates with 162 mg aspirin and crucially no increase in bleeding complications at the higher dose.
"a significantly lower rate of preeclampsia in high-risk patients who were treated with 162 milligram dose of aspirin for preeclampsia prophylaxis with bleeding complications that were not seen at the higher dose"
Chronic Hypertension - Where Even 162 mg May Not Work
A retrospective study from Henry Ford found no difference in superimposed preeclampsia rates between no aspirin, 81 mg, and 162 mg in women with chronic hypertension, suggesting a separate etiology.
"there were no differences in the incidence of superimposed preeclampsia between the three groups"
Who to Follow
Major Proponents:
- Rhonda Patrick, PhD - Covers aspirin research on FoundMyFitness
Synergies & Conflicts
Potentially Beneficial Combinations:
- Statin therapy: Complementary cardiovascular protection
- Blood pressure control: Reduces bleeding risk
- H. pylori treatment: Reduces GI bleeding risk if infected
Avoid Combining With:
- Other NSAIDs (ibuprofen may block aspirin's cardioprotective effect)
- Anticoagulants without medical supervision
- High-dose fish oil (additive bleeding risk)
- Alcohol (increases GI bleeding risk)
What People Say
Aspirin is one of the most widely used medications in history, with over 100 years of clinical use. It remains on the WHO List of Essential Medicines and is used by millions for cardiovascular prevention worldwide.